Product Details
Mircera 50 mcg**
Methoxy polyethylene glycol-epoetin beta50 mcg/0.3 mL
Solution for injection
ROA
Intravenous; Subcutaneous
Applicant Name
Roche Products Limited
NRN
A6-0121
Status
Active
Composition
Mircera 50 micrograms/0.3 mL solution for injection in pre-filled syringe. One pre-filled syringe contains 50 micrograms of Methoxy polyethylene glycol-epoetin beta* at a concentration of 167 micrograms/mL. The strength indicates the quantity of the protein moiety of the methoxy polyethylene glycol-epoetin beta molecule without consideration of the glycosylation. *Protein produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells and covalently conjugated to a linear methoxy-polyethylene glycol (PEG). The potency of methoxy polyethene glycol-epoetin beta should not be compared to the potency of another pegylated or non-pegylated protein of the same therapeutic class Excipients: L- Methionine 0.447 mg/0.3 mL, Sodium sulphate anhydrous1.704 mg/0.3 mL, Sodium dihydrogen phosphate monohydrate 0.414 mg/0.3 mL, Mannitol 9.000 mg/0.3 mL, Poloxamer 188 0.030 mg/0.3 mL, Hydrochloric acid diluted q.s (pH 6.2), Sodium hydroxide diluted solution q.s (Ph 6.2), Water for injection q.s ad total weight
ATC Code
B03XA03
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.3 mL (50 mcg) x 1’s (in pre-filled syringe)
Product Description
Solution for injection in pre-filled syringe. The solution is clear and colourless to slightly yellowish
Manufacturer Name
Roche Diagnostics GmbH
Manufacturer Country
GERMANY
Approval Date
2023-07-03
Expiry Date
2028-07-02